Simple.
Every day.

One dose.
Once daily.

• How it works
• Key efficacy
• Key safety
• Dosing

TRAJENTA^®:

Efficacy for type 2 diabetes.

(T2D)

• Efficacy vs placebo
• Sustained efficacy
• Regardless of renal function

TRAJENTA^®:

Key considerations
in daily practice.

• For which patients?
• What experts say
• Webinars
• Diabetes Discussions

Safety profile

TRAJENTA^®:

Favourable safety and tolerability profile.

For a broad range of T2D patients

• Adverse events
• CV profile

About JENTADUETO

Linagliptin / Metformin

single-pill
combination.

(SPC) for the treatment of type 2 diabetes (T2D)

• What it is
• Key efficacy
• Key safety

News

News.

• Trials
• Press Release

Play & learn

Play & learn.

• Go for a spin
• Spot the dots
• Quizzes & polls

Resources

Resources.

• Downloads
• FAQs